급성 세균성 전립선염의 임상경과에 관한 다기관 연구
Clinical Outcome of Acute Bacterial Prostatitis; A Multicenter Study
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: Proper guidelines concerning antibiotic administration for acute bacterial prostatitis (ABP) are unclear. We retrospectively analyzed treatment status and clinical outcomes to establish a proper treatment guideline. Materials and Methods: The clinical records of 669 patients from 21 hospitals diagnosed with ABP were reviewed. Prior manipulation, antibiotics administration, mean length of treatment, complication and procedure were analyzed. Results: The mean age of 538 patients (80.4%) without manipulation (group 1) and 131 patients (19.6%) with manipulation (group 2) was 58.3 years (range 19-88 years). Transrectal prostate biopsy was the most common cause of acute bacterial prostatitis (n=66; 50.4%). Of the clinical symptoms in the non-manipulation and manipulation groups, fever was most common (88.2% and 86.3%, respectively). Acute urinary retention (14.3% and 28.1%, respectively) was significantly increased in the manipulation group (p<0.05). Escherichia coli was the most frequently isolated bacterium from urine (72.0% and 66.7% of cases, respectively). Mean length of treatment was 6.5days and 7.9days, respectively; the difference was significant (p<0.05). Combination antibiotic therapy with third generation cephalosporin+aminoglycoside was used in 49.3% and 55.5% of cases, respectively. For single antibiotic therapy, second generation quinolones were used the most (35.5% and 34.3%, respectively). Sequale occurred in 29 group 1 patients (5.4%) and 20 group 2 patients (15.3%); the difference was significant (p<0.05). Conclusions: Prior manipulation was associated with 20% of ABP patients. Regardless of manipulation, clinical outcome was similar after treating with appropriate antibiotics.
Abstract
Purpose: Proper guidelines concerning antibiotic administration for acute bacterial prostatitis (ABP) are unclear. We retrospectively analyzed treatment status and clinical outcomes to establish a proper treatment guideline. Materials and Methods: The clinical records of 669 patients from 21 hospitals diagnosed with ABP were reviewed. Prior manipulation, antibiotics administration, mean length of treatment, complication and procedure were analyzed. Results: The mean age of 538 patients (80.4%) without manipulation (group 1) and 131 patients (19.6%) with manipulation (group 2) was 58.3 years (range 19-88 years). Transrectal prostate biopsy was the most common cause of acute bacterial prostatitis (n=66; 50.4%). Of the clinical symptoms in the non-manipulation and manipulation groups, fever was most common (88.2% and 86.3%, respectively). Acute urinary retention (14.3% and 28.1%, respectively) was significantly increased in the manipulation group (p<0.05). Escherichia coli was the most frequently isolated bacterium from urine (72.0% and 66.7% of cases, respectively). Mean length of treatment was 6.5days and 7.9days, respectively; the difference was significant (p<0.05). Combination antibiotic therapy with third generation cephalosporin+aminoglycoside was used in 49.3% and 55.5% of cases, respectively. For single antibiotic therapy, second generation quinolones were used the most (35.5% and 34.3%, respectively). Sequale occurred in 29 group 1 patients (5.4%) and 20 group 2 patients (15.3%); the difference was significant (p<0.05). Conclusions: Prior manipulation was associated with 20% of ABP patients. Regardless of manipulation, clinical outcome was similar after treating with appropriate antibiotics.
참고문헌 (19)
- Neal DE Jr, "Acute bacterial prostatitis. In: Textbook of prostatitis. 1st ed", pp.115~21 (1999), Isis Medical Media
- McRae SN, "Bacterial infections of the genitourinary tract, In Smith's general urology", pp.254~260 (2000), McGraw-Hill
- Neal DE Jr, "Treatment of acute prostatitis. In: Textbook of prostatitis. 1st ed", pp.279~84 (1999), Isis Medical Media
- Schaeffer AJ, "Diagnosis and treatment of prostatic infections", Urology, 36(5), pp.13~17 (1990)
- Naber KG, "EAU guidelines for the management of urinary and male genital tract infections. Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU)", Eur Urol, 40, pp.576~588 (2001)
- Nickel JC, "The overlapping lower urinary tract symptoms of benign prostatic hyperplasia and prostatitis", Curr Opin Urol, 16, pp.5~10 (2006)
- Chute CG, "The prevalence of prostatism: a population-based survey of urinary symptoms", J Urol, 150, pp.85~89 (1993)
- Caine M, "The present role of alpha-adrenergic blockers in the treatment of benign prostatic hypertrophy", J Urol, 136, pp.1~4 (1986)
- Shapiro E, "Pathophysiology of clinical benign prostatic hyperplasia", Urol Clin North Am, 22, pp.285~290 (1995)
- Kramer G, "Increased expression of lymphocyte-derived cytokines in benign hyperplastic prostate tissue, identification of the producing cell types, and effect of differentially expressed cytokines on stromal cell proliferation", Prostate, 52, pp.43~58 (2002)
- Kurita Y, "Transition zone index as a risk factor for acute urinary retention in benign prostatic hyperplasia", Urology, 51, pp.595~600 (1998)
- 김제희, "전립선비대증 환자에서 급성요폐의 예측인자", Korean Journal of Urology, 43(11), pp.949~955 (2002), 대한비뇨기과학회
- 이승언, "PSA 상승과 무증상 전립선염: 병리소견과의 연관성", Korean Journal of Urology, 47(1), pp.31~36 (2006), 대한비뇨기과학회
- Mishra VC, "Does intraprostatic inflammation have a role in the pathogenesis and progression of benign prostatic hyperplasia?", BJU Int, 100, pp.327~331 (2007)
- Jacobsen SJ, "Natural history of prostatism: risk factors for acute urinary retention", J Urol, 158, pp.481~487 (1997)
- Nickel JC, "Prostatitis: evolving management strategies", Urol Clin North Am, 26, pp.737~751 (1999)
- Kohnen PW, "Patterns of inflammation in prostatic hyperplasis: a histologic and bacteriologic study", J Urol, 121, pp.755~760 (1979)
- Nickel JC, "The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from REDUCE trial", Eur Urol, 54, pp.1379~1384 (2008)
- Handisurya A, "Differential expression of interleukin-15, a pro-inflammatory cytokine and T-cell growth factor, and its receptor in human prostate", Prostate, 49, pp.251~262 (2001)